1-6 months : Perform preliminary gross animal tests
6-12 months : Conduct animal safety and efficacy trails. Make strategic Alliance with large pharmaceutical firm.
12-30 months: Simultaneously prepare IND applications for European and United States FDA approvals, revive clinical trails with Italian Red Cross & Health Ministry, Erasmus University, Rotterdam, et,al.
Conduct trials for cardioplegia, cancer and cardiology in United States, but transfusion elsewhere.
30 -33 months: Submit license applications to Italian, Dutch, et, al. Begin production at Subcontractors.
33-36 months : Submit United States New Drug Application (NDA). Begin sales in Italy, Holland and other countries which accept their drug approvals.
36 months Plus: Begin United States & Canada sales for cancer and PTCA. Continue trails on other applications, transplant organ preservation. CO poisoning, sickle cell anemia, stoke and heart attack, et, al. |
